Gan, L., Lagerström‐Fermér, M., Ericsson, H., Nelander, K., Lindstedt, E., Michaëlsson, E., . . . Fuhr, R. (2019). Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers. Br J Clin Pharmacol.

Gan, Li‐Ming, et al. "Safety, Tolerability, Pharmacokinetics and Effect On Serum Uric Acid of the Myeloperoxidase Inhibitor AZD4831 in a Randomized, Placebo‐controlled, Phase I Study in Healthy Volunteers." Br J Clin Pharmacol 2019.

Gan, Li‐Ming, et al. "Safety, Tolerability, Pharmacokinetics and Effect On Serum Uric Acid of the Myeloperoxidase Inhibitor AZD4831 in a Randomized, Placebo‐controlled, Phase I Study in Healthy Volunteers." Br J Clin Pharmacol 2019.